4 Largecap 20 Per Cent Revenue Growth High ROE Promoter Backed Stocks to Watch for Future Multibagger Potential: Titan, Bajaj Auto, Torrent Pharma and Polycab
- November 13, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Titan Rs 4,921.90. Bajaj Auto Rs 10,945. Torrent Pharma Rs 4,727.20. Polycab Rs 8,080.50. Market caps from Rs 1.30 lakh crore to Rs 4.47 lakh crore. Data as of 12 Nov 2026.
Quick Answer
Titan, Bajaj Auto, Torrent Pharma and Polycab are the 4 picks in this 20 per cent revenue growth high ROE promoter backed stocks watchlist, with market caps between Rs 1.30 lakh crore and Rs 4.47 lakh crore. Titan stands out for the highest return on equity at 32.31%, while Bajaj Auto offers the lowest PE of the group at 26.26. PE ratios run from 26.26 to 83.23, so compare each one with its industry PE before investing. All figures are as of 12 November 2026.
20 per cent revenue growth high ROE promoter backed stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Titan, Bajaj Auto, Torrent Pharma and Polycab meet that test, with market caps from Rs 1.30 lakh crore to Rs 4.47 lakh crore and Titan offering the highest return on equity at 32.31%. Each of these companies has FY26 revenue growth of at least 20 per cent, a return on equity of at least 20 per cent and a promoter holding of at least 50 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with FY26 revenue growth of at least 20 per cent, a return on equity of at least 20 per cent and a promoter holding of at least 50 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening 20 per cent revenue growth high ROE promoter backed stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 12 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are 20 Per Cent Revenue Growth High ROE Promoter Backed Stocks and Why Do They Attract Multibagger Interest?
20 per cent revenue growth high ROE promoter backed stocks are shares of large companies whose sales grew by twenty per cent or more in FY26, whose return on equity is at least twenty per cent and in which the promoters own at least half of the business. The four here cover jewellery and watches, motorcycles, pharmaceuticals and cables.
Sales growth of one fifth or more shows strong demand, a high return on equity shows efficient use of capital, and a large promoter stake shows that the owners have their own wealth tied to the company. Within 20 per cent revenue growth high ROE promoter backed stocks, the four companies show rising profit. In 20 per cent revenue growth high ROE promoter backed stocks, each of the four also posted growth in the latest quarter. For 20 per cent revenue growth high ROE promoter backed stocks, both FY26 and the latest quarter showed growth. Whichever way you read 20 per cent revenue growth high ROE promoter backed stocks, the common thread is rising profit backed by complete financial data. For 20 per cent revenue growth high ROE promoter backed stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of 20 per cent revenue growth high ROE promoter backed stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for 20 per cent revenue growth high ROE promoter backed stocks before you decide.
20 Per Cent Revenue Growth High ROE Promoter Backed Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 12 November 2026. Bajaj Auto has the lowest PE of the group at 26.26, while Titan posts the highest return on equity at 32.31%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Titan Company | 4,921.90 | 4,46,502 | 77.52 | 46.75 | 32.31% | 0.93 | 3,506.50 to 5,186.70 |
| Bajaj Auto | 10,945 | 3,03,263 | 26.26 | 23.82 | 27.67% | 0.58 | 8,605.00 to 12,470.00 |
| Torrent Pharmaceuticals | 4,727.20 | 1,79,444 | 83.23 | 36.42 | 25.49% | 1.79 | 3,480.60 to 5,250.00 |
| Polycab India | 8,080.50 | 1,30,390 | 44.88 | 49.96 | 22.25% | 0.02 | 6,663.00 to 10,126.00 |
Titan: 23.26% Profit CAGR Since FY22
Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.
In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 79.66% over five years and 27.64% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026. The stock trades at a PE of 77.52 against an industry PE of 46.75, with a return on equity of 32.31%.
Bajaj Auto: Revenue Up 24.05% in FY26
Bajaj Auto makes motorcycles, three-wheelers and electric two-wheelers, and has a large export business. It reported FY26 revenue of Rs 65,087.22 crore, up 24.05% year on year, and net profit of Rs 10,574.50 crore, up 44.37%. Net profit has compounded at 14.44% a year since FY22, while revenue has grown 17.26% a year. Operating margin was 25.06% in FY26.
The stock trades at a PE of 26.26 against an industry PE of 23.82, with a return on equity of 27.67%. In the June 2026 quarter, revenue rose 64.02% to Rs 22,376.69 crore and net profit grew 44.26% to Rs 3,188.75 crore. The share price has gained 167.61% over five years and 14.49% over the past year. Domestic institutions raised their holding from 12.09% in June 2025 to 13.54% in June 2026.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 200.24% over five years and 32.19% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026. The stock trades at a PE of 83.23 against an industry PE of 36.42, with a return on equity of 25.49%.
Polycab: 33.79% Profit CAGR Since FY22
Polycab India is a leading maker of wires and cables in India, with a growing fast-moving electrical goods business. It reported FY26 revenue of Rs 29,120.04 crore, up 28.76% year on year, and net profit of Rs 2,708.43 crore, up 32.41%. Net profit has compounded at 33.79% a year since FY22, while revenue has grown 24.06% a year. Operating margin was 14.69% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
The stock trades at a PE of 44.88 against an industry PE of 49.96, below the sector average, with a return on equity of 22.25%. In the June 2026 quarter, revenue rose 38.90% to Rs 8,314.65 crore and net profit grew 32.84% to Rs 796.65 crore. The share price has gained 234.47% over five years. Foreign investors raised their holding from 11.44% in June 2025 to 19.00% in June 2026.
20 Per Cent Revenue Growth High ROE Promoter Backed Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these 20 per cent revenue growth high ROE promoter backed stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Titan | 88,136 | 5,073 | 44.62% | 32.00% | 23.26% | 14.61% |
| Bajaj Auto | 65,087.22 | 10,574.50 | 24.05% | 17.26% | 14.44% | 24.99% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 28.79% | 33.73% |
| Polycab | 29,120.04 | 2,708.43 | 28.76% | 24.06% | 33.79% | 15.12% |
Institutional Holding in Titan, Bajaj Auto, Torrent Pharma and Polycab
Institutional holding shows who is backing these 20 per cent revenue growth high ROE promoter backed stocks alongside the promoter. The table uses the latest reported quarter for each. Torrent Pharma has the deepest institutional backing, with FII and DII together holding 30.84% as of July 2026. Domestic institutions increased their holding over the past year in Titan (from 12.78% to 15.34%), Bajaj Auto (from 12.09% to 13.54%) and Torrent Pharma (from 9.28% to 12.87%). To see how this group fits the wider market, many investors compare it with the Nifty 50.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Titan | 52.90% | 15.38% | 15.34% | 16.38% | June 2026 |
| Bajaj Auto | 55.01% | 9.01% | 13.54% | 22.44% | June 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| Polycab | 61.46% | 19.00% | 7.62% | 11.92% | June 2026 |
Risks to Weigh in 20 Per Cent Revenue Growth High ROE Promoter Backed Stocks
Being careful with 20 per cent revenue growth high ROE promoter backed stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Torrent Pharma trades at a PE of 83.23 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between 20 Per Cent Revenue Growth High ROE Promoter Backed Stocks
Picking from 20 per cent revenue growth high ROE promoter backed stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.82 to 49.96) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Titan, Bajaj Auto, Torrent Pharma and Polycab live prices.
Conclusion
Among 20 per cent revenue growth high ROE promoter backed stocks, Titan stands out for the highest return on equity at 32.31%, Bajaj Auto for the lowest PE of the group at 26.26, Torrent Pharma for 20.34% revenue growth in FY26 and Polycab for the fastest profit growth, 33.79% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing 20 per cent revenue growth high ROE promoter backed stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on 20 Per Cent Revenue Growth High ROE Promoter Backed Stocks to Watch
Which are the best 20 per cent revenue growth high ROE promoter backed stocks to watch for multibagger potential?
Ans. Titan, Bajaj Auto, Torrent Pharma and Polycab are the 4 names this list highlights, with market caps of Rs 4,46,502 crore, Rs 3,03,263 crore, Rs 1,79,444 crore and Rs 1,30,390 crore respectively. Titan is notable for the highest return on equity at 32.31%. Bajaj Auto stands out for the lowest PE of the group at 26.26. Torrent Pharma offers 20.34% revenue growth in FY26. Polycab brings the fastest profit growth, 33.79% a year since FY22. These are watchlist names for 20 per cent revenue growth high ROE promoter backed stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Titan a good stock for long-term investors?
Ans. Titan has a return on equity of 32.31%, a PE of 77.52 against an industry PE of 46.75 and a market cap of Rs 4,46,502 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in 20 per cent revenue growth high ROE promoter backed stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Polycab become a multibagger from here?
Ans. Polycab has already gained 234.47% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in 20 per cent revenue growth high ROE promoter backed stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 33.79% a year since FY22, and FY26 revenue rose 28.76%. At a PE of 44.88 against an industry PE of 49.96, valuation should be checked against that growth before investing.
What is the market cap of Titan, Bajaj Auto, Torrent Pharma and Polycab?
Ans. As of 12 November 2026, Titan has a market cap of Rs 4,46,502 crore, Bajaj Auto has a market cap of Rs 3,03,263 crore, Torrent Pharma has a market cap of Rs 1,79,444 crore and Polycab has a market cap of Rs 1,30,390 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on 20 per cent revenue growth high ROE promoter backed stocks.
What are the risks of investing in 20 per cent revenue growth high ROE promoter backed stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 83.23 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Torrent Pharma trading at a PE of 83.23?
Ans. Torrent Pharma’s PE of 83.23 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in 20 per cent revenue growth high ROE promoter backed stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Titan, Bajaj Auto, Torrent Pharma and Polycab?
Ans. As of the latest reported quarter, FII and DII together hold 30.72% of Titan (15.38% and 15.34%), 22.55% of Bajaj Auto (9.01% and 13.54%), 30.84% of Torrent Pharma (17.97% and 12.87%) and 26.62% of Polycab (19.00% and 7.62%). Rising institutional holding is a useful signal in 20 per cent revenue growth high ROE promoter backed stocks, though it should be read with earnings trends rather than on its own.
